Key Insights

Highlights

Success Rate

81% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 62/100

Termination Rate

12.5%

3 terminated out of 24 trials

Success Rate

81.3%

-5.3% vs benchmark

Late-Stage Pipeline

13%

3 trials in Phase 3/4

Results Transparency

23%

3 of 13 completed with results

Key Signals

3 with results81% success

Data Visualizations

Phase Distribution

19Total
Not Applicable (13)
P 1 (1)
P 2 (2)
P 3 (3)

Trial Status

Completed13
Unknown5
Terminated3
Active Not Recruiting2
Not Yet Recruiting1

Trial Success Rate

81.3%

Benchmark: 86.5%

Based on 13 completed trials

Clinical Trials (24)

Showing 20 of 20 trials
NCT00707876Phase 2CompletedPrimary

Magnetic Resonance Angiography for Peripheral Arterial Disease (PAD)

NCT07142655CompletedPrimary

An Observational Study to Learn More About the Safety of Rivaroxaban in Participants With Peripheral Arterial Disease Who Had Surgery to Improve Blood Flow to Their Legs

NCT06457685Not ApplicableActive Not RecruitingPrimary

Amplitude Vascular Systems (AVS) Lithotripsy POWER PAD 2 Trial

NCT07340112Not Yet RecruitingPrimary

Expression of GLP1 Receptor on Peripheral Blood Mononuclear Cells in Advanced Peripheral Artery Disease: Paving the Way for GLP1R Agonists Treatment in Chronic Limb Threatening Ischemia

NCT05834673Not ApplicableTerminated

VICTORION-ASCERTAIN: Implementation Study (v-ASCERTAIN)

NCT02936622Not ApplicableCompletedPrimary

Paclitaxel-coated Peripheral Stents Used in the Treatment of Femoropopliteal Stenoses

NCT05246410Not ApplicableUnknown

A Clinical Trial to Evaluate the Efficacy and Safety of a Spot Stent System Used in Femoropopliteal Arteries.

NCT04753372Completed

Rivaroxaban Plus Aspirin in Patients With Chronic Coronary Syndrome and High Ischemic Risk

NCT05149664Not ApplicableActive Not RecruitingPrimary

A Non-significant Risk Clinical Study: Changes in Perfusion After Therapeutic Ultrasound in Patients With PAD

NCT00196066Phase 2CompletedPrimary

Evaluation of the Zilver Vascular Stent in the Iliac Arteries (ZIPS)

NCT03174522Phase 3TerminatedPrimary

The Efficacy and Safety of REX-001 to Treat Ischemic Ulcers in Subjects With CLI Rutherford Category 5 and DM

NCT04749732Not ApplicableUnknownPrimary

Home-based Exercise Therapy for Patients With PAD

NCT05498740Not ApplicableUnknownPrimary

Post-marketing Study in Femoral Popliteal Artery of Drug Coated Balloon Used for Treatment of Lower Limb Ischemia

NCT04631848UnknownPrimary

ULTRASCORE™ Focused Force PTA Balloon Angioplasty for CLI Patients With Below the Knee Vessel Disease

NCT03111238Phase 3TerminatedPrimary

The Efficacy and Safety of REX-001 to Treat Ischemic Rest Pain in Subjects With CLI Rutherford Category 4 and DM

NCT04746599Not ApplicableUnknown

Autologous Fat Grafting in the Treatment of Critical Limb Ischaemia

NCT02254837Not ApplicableCompletedPrimary

Zilver PTX Post-Market Study in Japan

NCT02254356Not ApplicableCompletedPrimary

Zilver Flex Post-Market Study in Japan

NCT02780349Not ApplicableCompletedPrimary

Evaluation of WIRION™ EPS in Lower Extremities Arteries

NCT01175850Not ApplicableCompletedPrimary

Randomized Trial of IN.PACT Admiral® Drug Coated Balloon vs Standard PTA for the Treatment of SFA and Proximal Popliteal Arterial Disease

Scroll to load more

Research Network

Activity Timeline